Although Bio is not among my 80 altcoin holdings, I am still optimistic about it, so I will analyze it and enter the market only if it drops to 0.2. Otherwise, I would rather miss it. The estimated market value will reach 7 billion U, and the price will reach 5.6 U, with 10 times of room to go. If it can fall to 0.2 U, there will be 30 times of profit space. The lowest price refers to the price that can be bought on Binance. In addition, my holdings are in months. Those who hold positions for less than ten minutes do not need to follow me. The above is purely personal analysis and does not constitute investment advice.
In line with the principle of not taking advantage of the last wave of the market, it is recommended to clear the position around 5u, at the latest in November 25th. You are welcome to come back and dig up the graves then.
Token Introduction: BIO Protocol is a decentralized science (DeSci) platform that aims to promote the funding, development and sharing of intellectual property (IP) for biotechnology research through a decentralized autonomous organization (DAO) model. Its goal is to solve the problem of uneven distribution of traditional biomedical research funds and encourage research on rare diseases, longevity research and other emerging health challenges.
Section: Desci First release date: 2025.1.3 Total volume: 3.32 billion Circulation: 1.2965 billion Circulation market value: 733 million Circulation market value ranking: 118 Listed exchanges: 14
Official social media: Twitter: 96,000 people, tweeting every day
Token distribution and unlocking: Community auction: 20% Community airdrop: 6% Advisors: 4.2% Ecosystem incentives: 25% Molecule Ecosystem Fund: 5% Investors: 13.6% Core contributors: 21.2% Molecule: 5%
Unlocking status: No unlocking in the short term, specific unlocking information will be added later
Project financing: 2024-08-20 Public offering round 6.22 million USD 2024-11-08 Strategic financing, the specific amount is not disclosed Binance Labs 2024-11-14 Public offering round 4.74 million USD
Project CEO and executive information: Paul Kohlhaas is the founder and CEO of the Molecule protocol, an entrepreneur and economist who is passionate about open source utility networks. His strong interest in pharmaceutical innovation led him to found the Molecule networked marketplace, which can provide distributed R&D and funding support for new chemical intellectual property. His research focuses on the use of token economy and autonomous market design to promote new incentives and legal structures for open source collaboration. He graduated from the University of St. Gallen with a degree in economics and politics, co-founded the blockchain architecture studio Linum Labs, and worked at ConsenSys for a year and a half. The uPort he participated in can be regarded as a pioneer in the early practical application of digital identity.
Clemens Ortlepp is the co-founder and chief product officer of BIO Protocol and founder of MTX Studio, focusing on decentralized technology innovation. He leads the creation of BIO Protocol user-end products to ensure that the platform has a friendly interactive interface and efficient operation process.
Project Features:
Biotechnology professionalism: As a digital currency focused on biotechnology, BIOcoin is professional and unique. It provides convenience and opportunities for biotechnology companies by providing relevant financial and technological support.
Blockchain technology support: Blockchain, as a distributed ledger technology, can ensure the security and transparency of transactions. BIO coin uses blockchain technology to ensure the authenticity of transactions and prevent the risk of double payment and tampering.
Innovative financial model: The emergence of BIO coin provides a new financing model for biotech companies. By issuing tokens, it can attract investors to provide financial support for biotech projects and accelerate the research and development and promotion of projects.
Promoting Technological Innovation: The goal of BIOcoin is to promote innovation and development in biotechnology. By providing funding and support, it can help biotechnology companies promote technological research and development and improve the development of fields such as medicine, agriculture and environmental protection.
Global transactions: BIOcoin can be traded worldwide without going through intermediaries and traditional financial institutions, reducing transaction costs and time. This allows more biotech companies to obtain international financial support and opportunities for exchange and cooperation.
BIO Protocol’s existing DAOs include: VitaDAO: Funding longevity research and democratizing intellectual property ownership HairDAO: Developing hair loss treatments through an open-source R&D network ValleyDAO: Funding synthetic biology research AthenaDAO: Promoting research and education in women’s health CryoDAO: Investing in cryopreservation research projects PsyDAO: Exploring and advancing safe psychedelic therapies Cerebrum DAO: Preventing neurodegeneration and extending brain life
Important project events: 2024-08-22 Decentralized biotech protocol BIO Protocol has completed $6.22 million in financing 2024-11-08 Binance Labs announced investment in BIO Protocol 2024-11-13 BIO Protocol has completed Genesis Round 2.5 community financing, raising a total of $4.74 million 2024-12-23 Binance Launchpool launched Bio Protocol (BIO)